Pro Medicus Ltd banner

Pro Medicus Ltd
ASX:PME

Watchlist Manager
Pro Medicus Ltd Logo
Pro Medicus Ltd
ASX:PME
Watchlist
Price: 139.81 AUD -1.7% Market Closed
Market Cap: AU$14.6B

Pro Medicus Ltd
Other Liabilities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Pro Medicus Ltd
Other Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Pro Medicus Ltd
ASX:PME
Other Liabilities
AU$39m
CAGR 3-Years
19%
CAGR 5-Years
21%
CAGR 10-Years
80%
4DMedical Ltd
ASX:4DX
Other Liabilities
AU$143.1m
CAGR 3-Years
2 526%
CAGR 5-Years
319%
CAGR 10-Years
N/A
CogState Ltd
ASX:CGS
Other Liabilities
$2.8m
CAGR 3-Years
-15%
CAGR 5-Years
-24%
CAGR 10-Years
58%
Alcidion Group Ltd
ASX:ALC
Other Liabilities
AU$642k
CAGR 3-Years
-14%
CAGR 5-Years
32%
CAGR 10-Years
N/A
A
Artrya Ltd
ASX:AYA
Other Liabilities
AU$40k
CAGR 3-Years
30%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
B
BlinkLab Ltd
ASX:BB1
Other Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Pro Medicus Ltd
Glance View

Pro Medicus Ltd, an Australian company founded in 1983, has etched its name in the field of healthcare IT, primarily through its innovative medical imaging software solutions. The brainchild of Dr. Sam Hupert and Anthony Hall, the company originally sought to provide radiology practices with digital solutions for image management and viewing. Over the years, Pro Medicus has meticulously evolved its offerings to become a leader in picture archiving and communication systems (PACS), radiology information systems (RIS), and an expanding range of e-health solutions. Its flagship product, Visage 7, is renowned for delivering fast and sophisticated viewing capabilities, enabling radiologists to efficiently interpret complex imaging data. Under its hood, the company’s technology is powered by advanced streaming capabilities, allowing for large files to be quickly accessed and reviewed, essential for high-demand environments. The monetization model of Pro Medicus largely revolves around licensing agreements for its software, alongside service and support fees, ensuring a steady and recurring revenue stream. The company has successfully leveraged its expertise to penetrate key markets, notably the United States and Europe, where it partners with some of the most prestigious hospitals and research institutions. By focusing on high-end offerings and fostering long-term client relationships, Pro Medicus has cemented a premium positioning in the healthcare IT landscape. The strategic focus on innovation, coupled with a keen understanding of the evolving needs of healthcare providers, allows Pro Medicus to continually refine its services, ensuring it remains at the forefront of technological advancements that ultimately enhance diagnostic efficiency and patient outcomes.

PME Intrinsic Value
22.19 AUD
Overvaluation 84%
Intrinsic Value
Price AU$139.81

See Also

What is Pro Medicus Ltd's Other Liabilities?
Other Liabilities
39m AUD

Based on the financial report for Dec 31, 2025, Pro Medicus Ltd's Other Liabilities amounts to 39m AUD.

What is Pro Medicus Ltd's Other Liabilities growth rate?
Other Liabilities CAGR 10Y
80%

Over the last year, the Other Liabilities growth was 36%. The average annual Other Liabilities growth rates for Pro Medicus Ltd have been 19% over the past three years , 21% over the past five years , and 80% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett